Table 2 Pre-treatment to 3-month follow-up observed mean and standard deviations for primary outcomes
Variable | All patients (n = 122) | All Preference Trial patients (n = 74) | Preference Trial (n = 74) | Accepted for Self-Guided Only (n = 48) | Statisticala Significance χ2 or t-test | |
|---|---|---|---|---|---|---|
Guided (n = 60) | Self-Guided (n = 14) | Met Severity criteria but Out-of-Province (n = 48) | ||||
TLFB | Â | Â | Â | Â | Â | Â |
 Pretreatment | 37.24 (17.38) | 37.82 (18.30) | 38.85 (17.70) | 33.43 (20.79) | 36.33 (16.02) | p = .32 |
 Midtreatment | 15.20 (15.42) | 15.79 (16.51) | 16.43 (17.74) | 12.40 (6.60) | 14.17 (13.47) | p = .48 |
 Posttreatment | 13.67 (15.06) | 13.65 (14.12) | 14.08 (15.02) | 11.33 (7.94) | 13.69 (16.64) | p = .60 |
 Followup | 16.58 (14.78) | 17.00 (15.76) | 16.61 (16.37) | 18.75 (13.44) | 15.97 (13.46) | p = .73 |
HDD | ||||||
 Pretreatment | 4.11 (1.98) | 3.99 (2.00) | 4.13 (1.96) | 3.36 (2.10) | 4.31 (1.97) | p = .19 |
 Midtreatment | 1.65 (2.02) | 1.62 (1.93) | 1.75 (2.04) | 0.90 (0.99) | 1.69 (2.20) | p = .20 |
 Posttreatment | 1.36 (2.02) | 1.37 (1.95) | 1.51 (2.03) | 0.67 (1.41) | 1.35 (2.15) | p = .24 |
 Followup | 1.70 (2.06) | 1.70 (1.97) | 1.58 (1.98) | 2.25 (1.98) | 1.70 (2.22) | p = .39 |